Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7017292
Reference Type
Journal Article
Title
Performing EUS during COVID-19 postendemic period: A report from endoscopy center in Wuhan
Author(s)
Zhao, Y; Chen, Q; Guo, Q; Chen, N; Hou, W; Wang, Y; Qu, W; Tang, SJ; Sun, S; Cheng, B; ,
Year
2020
Publisher
WOLTERS KLUWER MEDKNOW PUBLICATIONS
Location
MUMBAI
Page Numbers
93-97
Language
English
PMID
32675462
DOI
10.4103/eus.eus_37_20
Web of Science Id
WOS:000641024500003
URL
http://www.eusjournal.com/text.asp?2021/10/2/93/289555
Exit
Abstract
In early April 2020, the 3-month-long city-wide lockdown was lifted in Wuhan, the epicenter of China during Coronavirus Disease 2019 (COVID-19) global pandemic. However, continuing precautions are still practiced considering the risk of transmission from asymptomatic carriers. Given that COVID-19 is spread via airborne droplets, including aspiration of oral and fecal material through endoscopes, our endoscopy center has strategically assigned health-care providers to ensure triage workflow and to minimize concomitant exposure from potential asymptomatic carriers. Here, we share the experience of performing EUS-FNA during the COVID-19 pandemic and postendemic periods. We illustrate our workflow using a patient with a left adrenal mass as an example and followed a biosafety level-2 standard. We believe all endoscopy centers need to focus on these three directions: (1) pre-EUS patients risk assessment and triage, (2) Personal protective equipment (PPE), and (3) dressing code modalities. We fully adopted them in our hospital to reduce COVID-19 resurgence risk.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity